Identification of previously undiagnosed left ventricular systolic dysfunction: Community screening using natriuretic peptides and electrocardiography

European Journal of Heart Failure

Volumn 5, Issue 6, 2003, Pages 775-782

  Ng, Leong L ^a   Loke, Ian ^a   Davies, Joan E ^a   Khunti, Kamlesh ^b   Stone, Margaret ^b   Abrams, Keith R ^c   Chin, Derek T ^d   Squire, Iain B ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b Department of General Practice ^*  (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Electrocardiogram; Heart failure; Natriuretic peptide

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; N TERMINAL PROATRIAL NATRIURETIC PEPTIDE; NATRIURETIC FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; COMMUNITY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECG ABNORMALITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RECEIVER OPERATING CHARACTERISTIC; SCREENING; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; ROC CURVE; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 1042267416     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(03)00154-5     Document Type: Article

References (27)

1. Levy D., Kenchaiah S., Larson M.G., et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 347:2002;1397-1402.
2. Haldeman G.A., Croft J.B., Giles W.H., Rashidee A. Hospitalisation of patients with heart failure: national discharge survey 1985-1995. Am Heart J. 137:1999;352-360.
3. Stewart S., MacIntyre K., MacLeod M.M.C., Bailey A.E., Capewell S., McMurray J.J. Trends in hospitalisation for heart failure in Scotland 1990-1996. Eur Heart J. 22:2001;209-217.
4. Stewart S., MacIntyre K., Capewell S., McMurray J.J.V. Heart failure and the aging population: an increasing burden in the 21st century? Heart. 89:2003;49-53.
5. MacIntyre K., Capewell S., Stewart S., et al. Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation. 102:2000;1126-1131.
6. McMurray J., Hart W., Rhodes G. An evaluation of the economic cost of heart failure to the National Health Service in the United Kingdom. Br J Med Econ. 6:1993;99-110.
7. McDonagh T.A., Morrison C.E., Lawrence A., et al. Symptomatic and asymptomatic left ventricular dysfunction in an urban population. Lancet. 350:1997;829-833.
8. Davies M.K., Hobbs F.D.R., Davis R., et al. Prevalence of left ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening Study: a population based study. Lancet. 358:2001;439-444.
9. Hobbs F.D.R. Primary care physicians; champions of or an impediment to optimal care of the patient with heart failure. Eur J Heart Failure. 1:1999;11-15.
10. Talwar S., Squire I.B., Davies J.E., Barnett D.B., Ng L.L. Plasma pro brain natriuretic peptide and the ECG in the assessment of left ventricular systolic dysfunction in a high risk population. Eur Heart J. 20:1999;1736-1744.
11. Houghton A.R., Sparrow N.J., Toms E., Cowley A.J. Should general practitioners use the electrocardiogram to select patients with suspected heart failure for echocardiography? Int J Cardiol. 62:1997;31-36.
12. McDonagh T.A., Robb S.D., Murdoch D.R., et al. Biochemical detection of left ventricular systolic dysfunction. Lancet. 351:1998;9-13.
13. Hobbs F.D.R., Davis R.C., Roalfe A.K., Hare R., Davies M.K., Kenkre J.E. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ. 324:2002;1498-1500.
14. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 347:2002;161-167.
15. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr. 2:1989;358-367.
16. Hedberg P., Lonnberg I., Jonason T., et al. Left ventricular systolic dysfunction in 75-year-old men and women; a population-based study. Eur Heart J. 22:2001;623-626.
17. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods, 2nd edn., Geneva:WHO Monograph Series, No. 56.
18. Ng L.L., O'Brien R.J., Demme B., Jennings S. A non-competitive immunochemiluminometric assay for cardiotrophin-1 detects elevated plasma levels in human heart failure. Clin Sci. 102:2002;411-416.
19. Omland T., Persson A., Ng L.L., et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation. 106:2002;2913-2918.
20. Schumacher M., Hollander N., Sauerbrei W. Resampling and cross-validation techniques: a tool to reduce bias caused by model building. Stat Med. 16:1997;2813-2828.
21. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 143:1982;29-36.
22. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating curves: a non-parametric approach. Biometrics. 44:1988;837-845.
23. Landray M.J., Lehman R., Arnold I. Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study. BMJ. 320:2000;985-986.
24. Smith H., Pickering R.M., Struthers A., Simpson I., Mant D. Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study. BMJ. 320:2000;906-908.
25. Vasan R.S., Benjamin E.J., Larson M.G., et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and dysfunction. J Am Med Assoc. 288:2002;1252-1259.
26. Sur D.K., Kaye L., Mikus M., et al. Accuracy of electrocardiogram reading by family practice residents. Fam Med. 32:2000;315-319.
27. de Lemos J.A., Morrow D.A., Bentley J.H., Goad J., Morena A. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 345:2001;1014-1021.